Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report-Reference-Cited by-同舟云学术

Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report

Published:2020-10-06 Issue:19 Volume:8 Page:4527-4534
ISSN:2307-8960
Container-title:World Journal of Clinical Cases
language:
Short-container-title:WJCC

Author:

Li Ben,Li Guan-Wu,Xue Luan,Chen Yue-Ying

Publisher

Baishideng Publishing Group Inc.

Subject

General Medicine

Reference26 articles.

1. Chronic mandibular osteomyelitis with suspected underlying synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: a case report

2. Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic 1987; 54: 187-196

3. SAPHO syndrome: a review

4. The SAPHO Syndrome

5. SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Janus kinase inhibitor tofacitinib successfully treated palmoplantar pustulosis after switching from secukinumab: A case report and review of the literature;International Immunopharmacology;2024-09

2. Is JAK effective in treating recurrent SAPHO syndrome? TwHF might be a good choice;Medicine;2024-07-19

3. Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with Baricitinib, a Janus Kinase Inhibitor;Clinical, Cosmetic and Investigational Dermatology;2024-03

4. Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case report;Journal of Medical Case Reports;2024-02-16

5. Tofacitinib: a successful treatment option for SAPHO syndrome;International Journal of Dermatology;2024-02-15